The Point-Guard™ Cerebral Embolic Protection is an investigational device. Limited by federal (United States) law to investigational use and not cleared for sale by any regulatory authority, foreign or domestic. Exclusively for clinical investigations. Not approved by FDA and not for sale in the United States or other International Markets.